KeyCorp Comments on Surgery Partners, Inc.’s FY2024 Earnings (NASDAQ:SGRY)

Surgery Partners, Inc. (NASDAQ:SGRY) – Equities researchers at KeyCorp issued their FY2024 earnings estimates for Surgery Partners in a research note issued on Thursday, October 10th. KeyCorp analyst M. Gillmor expects that the company will post earnings per share of $0.81 for the year. KeyCorp currently has a “Sector Weight” rating on the stock. The consensus estimate for Surgery Partners’ current full-year earnings is $0.86 per share.

Several other brokerages have also issued reports on SGRY. Royal Bank of Canada reiterated an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a research note on Wednesday, August 7th. UBS Group initiated coverage on shares of Surgery Partners in a research note on Monday. They issued a “buy” rating and a $38.00 price target on the stock. Macquarie initiated coverage on shares of Surgery Partners in a research note on Friday, June 28th. They set an “outperform” rating and a $31.00 price objective on the stock. Citigroup lowered their price objective on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. Finally, StockNews.com lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Surgery Partners has an average rating of “Moderate Buy” and a consensus target price of $39.63.

Surgery Partners Stock Up 4.2 %

Shares of SGRY stock opened at $31.75 on Monday. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96. Surgery Partners has a 1 year low of $22.05 and a 1 year high of $36.92. The firm’s fifty day moving average price is $30.79 and its two-hundred day moving average price is $27.81. The firm has a market capitalization of $4.04 billion, a P/E ratio of -117.59, a PEG ratio of 2.33 and a beta of 2.75.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The firm had revenue of $762.10 million for the quarter, compared to analyst estimates of $735.94 million. During the same period in the previous year, the business earned $0.25 EPS. The company’s revenue was up 14.2% compared to the same quarter last year.

Institutional Trading of Surgery Partners

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Quarry LP boosted its holdings in Surgery Partners by 133.1% in the 2nd quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares during the period. DekaBank Deutsche Girozentrale boosted its holdings in Surgery Partners by 102.0% in the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after purchasing an additional 1,375 shares during the period. EntryPoint Capital LLC boosted its holdings in Surgery Partners by 257.1% in the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after purchasing an additional 4,607 shares during the period. Creative Planning bought a new stake in Surgery Partners in the 3rd quarter valued at about $258,000. Finally, Capstone Investment Advisors LLC boosted its holdings in Surgery Partners by 38.7% in the 1st quarter. Capstone Investment Advisors LLC now owns 9,151 shares of the company’s stock valued at $273,000 after purchasing an additional 2,551 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.